Related Articles
Association of intestinal dysbiosis with susceptibility to multiple sclerosis: Evidence from different population studies (Review)
Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)
Nobiletin alleviates palmitic acid‑induced NLRP3 inflammasome activation in a sirtuin 1‑dependent manner in AML‑12 cells
Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review)
Resolvin D2 suppresses NLRP3 inflammasome by promoting autophagy in macrophages